Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides
Bioconjugate Chemistry · 18.06.2025 · 36 (6) · 1319-1328
DOI: 10.1021/acs.bioconjchem.5c00167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 23.05.2025. Verfasst von Lin Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental BioEngineering, TechMed Institute, University of Twente, Enschede 7522 NB, The Netherlands. Hauptthemen laut MEDLINE: Polysaccharides, Genetic Engineering, Single-Domain Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Site-selective modifications of proteins, without compromising their biological activity, are highly sought after due to their critical role in many biomedical applications. Here, we established a universal and efficient approach for site-selective conjugation of a variable domain of single-chain heavy-chain only antibody fragments (VHH) to polysaccharides using thiol-maleimide chemistry, known for its specificity and efficiency. This is achieved by genetically engineering an unpaired cysteine (Cys) residue in a C-terminal extension of VHHs. In this study, we synthesized two maleimide-functionalized polysaccharides, i.e., dextran-maleimide (Dex-Mal) and hyaluronic acid-maleimide (HA-Mal), for protein conjugation. Six distinct VHHs were selected and engineered with C-terminal extensions containing Cys residues for conjugation with Dex-Mal and HA-Mal. Conjugation efficiency varied among VHHs due to structural heterogeneity, which influenced the reactivity of the engineered Cys residues. One VHH, specific to TNFα (anti-TNFα-VHH), exhibited low conjugation efficiency (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Developmental BioEngineering, TechMed Institute, University of Twente, Enschede 7522 NB, The Netherlands.
- Orthros Medical BV, Drosteweg 8, 8101NB Raalte, The Netherlands.
- QVQ Holding BV, Yalelaan 1, 3584CL Utrecht, The Netherlands.
ORCID-Profile: Bram Zoetebier
Förderung
- China Scholarship Council
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Zhong, L., Morshuis, L. C. M., Koerselman, M., Memelink, A., Kolecka, A., Heukers, R., Verrips, T., Karperien, M., & Zoetebier, B. (2025). Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides. Bioconjugate Chemistry, 36(6), 1319-1328. https://doi.org/10.1021/acs.bioconjchem.5c00167
Vancouver
Zhong L, Morshuis LCM, Koerselman M, Memelink A, Kolecka A, Heukers R, et al. Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides. Bioconjugate Chemistry. 2025;36(6):1319-1328. doi:10.1021/acs.bioconjchem.5c00167
BibTeX
@article{Zhong2025,
author = {Zhong, Lin and Morshuis, Lisanne C M and Koerselman, Michelle and Memelink, Angela and Kolecka, Anna and Heukers, Raimond and Verrips, Theo and Karperien, Marcel and Zoetebier, Bram},
title = {Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides},
journal = {Bioconjugate Chemistry},
year = {2025},
volume = {36},
number = {6},
pages = {1319--1328},
doi = {10.1021/acs.bioconjchem.5c00167}
}
EUVIMED